A three-day treatment option for Cleocin Vaginal Cream 2% has been approved for the treatment of bacterial vaginosis in non-pregnant women. Cleocin Vaginal Cream was first marketed in the U.S. in 1992, as a seven-day course therapy. Along with approval of the three-day therapy option, the FDA has also added pregnant women in their third trimester to the population who can be treated with the seven-day treatment option.
Available only by prescription, Cleocin Vaginal Cream three-day treatment option comes in a new 21-gram tube with three disposable applicators.
The Cleocin (clindamycin phosphate) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.